In the Matter of Certain Endoscopic Probes for Use in Argon Plasma Coagulation Systems; Notice of Commission Decision To Review in Part an Initial Determination and on Review To Affirm the Administrative Law Judge's Determination That There is No Violation of Section 337, 15195 [E8-5762]
Download as PDF
Federal Register / Vol. 73, No. 56 / Friday, March 21, 2008 / Notices
Haines Block ACEC. Establishment of an
ACEC would require an RMP
amendment. In the interim, the lands
will be managed as they are currently.
All other portions of the Approved
RMP are identical to those set forth in
July 2006.
No inconsistencies with State or local
plans, policies, or programs were
identified during the Governor’s
consistency review of the Proposed
RMP/Final EIS.
Dated: January 18, 2008.
Thomas P. Lonnie,
State Director.
[FR Doc. E8–5646 Filed 3–20–08; 8:45 am]
BILLING CODE 4310–JA–P
INTERNATIONAL TRADE
COMMISSION
[Inv. No. 337–TA–569]
In the Matter of Certain Endoscopic
Probes for Use in Argon Plasma
Coagulation Systems; Notice of
Commission Decision To Review in
Part an Initial Determination and on
Review To Affirm the Administrative
Law Judge’s Determination That There
is No Violation of Section 337
U.S. International Trade
Commission.
ACTION: Notice.
AGENCY:
Notice is hereby given that
the U.S. International Trade
Commission has determined to review
in part an initial determination (‘‘ID’’)
issued by the presiding administrative
law judge (‘‘ALJ’’) determining that
there is no violation of section 337 of
the Tariff Act of 1930. Specifically, the
Commission has determined to review
the portions of the ALJ’s determination
relating to construction of the claim
term ‘‘predetermined minimum safety
distance’’ and associated findings on
infringement and domestic industry. On
review, the Commission has determined
to take no position with respect to these
issues, and to affirm the ALJ’s
determination of no violation of section
337.
FOR FURTHER INFORMATION CONTACT:
Jonathan J. Engler, Esq., Office of the
General Counsel, U.S. International
Trade Commission, 500 E Street, SW.,
Washington, DC 20436, telephone 202–
205–3112. Copies of the public version
of the ID and all nonconfidential
documents filed in connection with this
investigation are or will be available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
mstockstill on PROD1PC66 with NOTICES
SUMMARY:
VerDate Aug<31>2005
18:33 Mar 20, 2008
Jkt 214001
Street, SW., Washington, DC 20436,
telephone 202–205–2000. Hearingimpaired persons are advised that
information on this matter can be
obtained by contacting the
Commission’s TDD terminal on 202–
205–1810. General information
concerning the Commission may also be
obtained by accessing its Internet server
(https://www.usitc.gov). The public
record for this investigation may be
viewed on the Commission’s electronic
docket (EDIS) at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION: This
investigation was instituted by the
Commission based on a complaint filed
by ERBE Elektromedizin GmbH and
ERBE USA, Inc. (collectively, ‘‘ERBE’’).
71 FR 29386 (May 16, 2006). The
complaint alleged violations of section
337 of the Tariff Act of 1930, 19 U.S.C.
1337, in the importation into the United
States, the sale for importation, and the
sale within the United States after
importation of certain endoscopic
probes for use in argon plasma
coagulation systems by reason of
infringement of 10 claims of U.S. Patent
No. 5,720,745 (‘‘the ’745 patent’’) and
infringement of U.S. Supplemental
Trademark Registration No. 2,637,630
(‘‘the ’630 registration’’). The complaint
also alleged that a domestic industry
exists and/or is in the process of being
established, with regard to the ’745
patent and the ’630 registration under
subsection (a)(2). The notice of
investigation named Canady
Technology, LLC of Hampton, Virginia
(‘‘Canady USA’’); Canady Technology
Germany GmbH of Germany (‘‘Canady
Gmbh’’); and KLS Martin as the
respondents. The complaint requested
that the Commission institute an
investigation pursuant to Section 337
and, after the investigation, issue a
permanent exclusion order and a
permanent cease and desist order. The
investigation has been terminated as to
KLS Martin on the basis of a settlement
agreement.
On January 16, 2008 the
administrative law judge issued a final
ID finding no violation of section 337 in
this investigation. The ALJ found no
violation of section 337 through the
importation or sale for importation of
argon plasma probes sold by the Canady
in the United States. In particular, the
ID found that the Canady probes do not
directly infringe the ’745 patent; that
even if there were direct infringement
there is no contributory infringement or
inducement to infringe the ’745 patent
by Canady; that ERBE has not shown
that there is a domestic industry with
respect to the ’745 patent because the
ERBE products are not used to practice
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
15195
its claims; and that the ’745 patent is not
invalid.
On January 28, 2008, ERBE filed its
petition for review of the ID, challenging
the ALJ’s findings with respect to no
infringement of the ’745 patent and the
absence of a domestic industry. Canady
filed its Contingent Petition for review
of the ID on January 29, 2008.
Having examined the record of this
investigation, including the ALJ’s final
ID and the submissions of the parties,
the Commission has determined to
review the portions of the ALJ’s
determination relating to the
construction of the phrase
‘‘predetermined minimum safety
distance’’ the associated findings on
infringement and domestic industry. On
review, the Commission has determined
to take no position with respect to these
issues, and to affirm the ALJ’s
determination of no violation of section
337.
This action is taken under the
authority of section 337 of the Tariff Act
of 1930, as amended, 19 U.S.C. 1337,
and Commission rule 210.42, 19 CFR
210.42.
By order of the Commission.
Issued: March 17, 2008.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E8–5762 Filed 3–20–08; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Notice of Lodging of a Consent Decree
Under the Clean Water Act
Notice is hereby given that on March
14, 2008, a proposed Consent Decree
(‘‘Decree’’) in United States &
Commonwealth of Kentucky v.
Lexington Fayette Urban County
Government, Civil Action No. 5:06–cv–
00386–KSF, was lodged with the United
States District Court for the Eastern
District of Kentucky, Central Division.
The proposed Consent Decree would
resolve claims against the Lexington
Fayette Urban County Government
(‘‘LFUCG’’) for the Clean Water Act
violations involving the municipal
separate storm sewer system and the
sanitary sewer system alleged in the
complaint filed in November 2006 by
the United States and the
Commonwealth of Kentucky. The
proposed Consent Decree provides for
LFUCG to perform injunctive measures
as described in the Consent Decree, to
pay a civil penalty of $425,000 to the
United States, and to perform federal
Supplemental Environmental Projects
E:\FR\FM\21MRN1.SGM
21MRN1
Agencies
[Federal Register Volume 73, Number 56 (Friday, March 21, 2008)]
[Notices]
[Page 15195]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-5762]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Inv. No. 337-TA-569]
In the Matter of Certain Endoscopic Probes for Use in Argon
Plasma Coagulation Systems; Notice of Commission Decision To Review in
Part an Initial Determination and on Review To Affirm the
Administrative Law Judge's Determination That There is No Violation of
Section 337
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that the U.S. International Trade
Commission has determined to review in part an initial determination
(``ID'') issued by the presiding administrative law judge (``ALJ'')
determining that there is no violation of section 337 of the Tariff Act
of 1930. Specifically, the Commission has determined to review the
portions of the ALJ's determination relating to construction of the
claim term ``predetermined minimum safety distance'' and associated
findings on infringement and domestic industry. On review, the
Commission has determined to take no position with respect to these
issues, and to affirm the ALJ's determination of no violation of
section 337.
FOR FURTHER INFORMATION CONTACT: Jonathan J. Engler, Esq., Office of
the General Counsel, U.S. International Trade Commission, 500 E Street,
SW., Washington, DC 20436, telephone 202-205-3112. Copies of the public
version of the ID and all nonconfidential documents filed in connection
with this investigation are or will be available for inspection during
official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the
Secretary, U.S. International Trade Commission, 500 E Street, SW.,
Washington, DC 20436, telephone 202-205-2000. Hearing-impaired persons
are advised that information on this matter can be obtained by
contacting the Commission's TDD terminal on 202-205-1810. General
information concerning the Commission may also be obtained by accessing
its Internet server (https://www.usitc.gov). The public record for this
investigation may be viewed on the Commission's electronic docket
(EDIS) at https://edis.usitc.gov.
SUPPLEMENTARY INFORMATION: This investigation was instituted by the
Commission based on a complaint filed by ERBE Elektromedizin GmbH and
ERBE USA, Inc. (collectively, ``ERBE''). 71 FR 29386 (May 16, 2006).
The complaint alleged violations of section 337 of the Tariff Act of
1930, 19 U.S.C. 1337, in the importation into the United States, the
sale for importation, and the sale within the United States after
importation of certain endoscopic probes for use in argon plasma
coagulation systems by reason of infringement of 10 claims of U.S.
Patent No. 5,720,745 (``the '745 patent'') and infringement of U.S.
Supplemental Trademark Registration No. 2,637,630 (``the '630
registration''). The complaint also alleged that a domestic industry
exists and/or is in the process of being established, with regard to
the '745 patent and the '630 registration under subsection (a)(2). The
notice of investigation named Canady Technology, LLC of Hampton,
Virginia (``Canady USA''); Canady Technology Germany GmbH of Germany
(``Canady Gmbh''); and KLS Martin as the respondents. The complaint
requested that the Commission institute an investigation pursuant to
Section 337 and, after the investigation, issue a permanent exclusion
order and a permanent cease and desist order. The investigation has
been terminated as to KLS Martin on the basis of a settlement
agreement.
On January 16, 2008 the administrative law judge issued a final ID
finding no violation of section 337 in this investigation. The ALJ
found no violation of section 337 through the importation or sale for
importation of argon plasma probes sold by the Canady in the United
States. In particular, the ID found that the Canady probes do not
directly infringe the '745 patent; that even if there were direct
infringement there is no contributory infringement or inducement to
infringe the '745 patent by Canady; that ERBE has not shown that there
is a domestic industry with respect to the '745 patent because the ERBE
products are not used to practice its claims; and that the '745 patent
is not invalid.
On January 28, 2008, ERBE filed its petition for review of the ID,
challenging the ALJ's findings with respect to no infringement of the
'745 patent and the absence of a domestic industry. Canady filed its
Contingent Petition for review of the ID on January 29, 2008.
Having examined the record of this investigation, including the
ALJ's final ID and the submissions of the parties, the Commission has
determined to review the portions of the ALJ's determination relating
to the construction of the phrase ``predetermined minimum safety
distance'' the associated findings on infringement and domestic
industry. On review, the Commission has determined to take no position
with respect to these issues, and to affirm the ALJ's determination of
no violation of section 337.
This action is taken under the authority of section 337 of the
Tariff Act of 1930, as amended, 19 U.S.C. 1337, and Commission rule
210.42, 19 CFR 210.42.
By order of the Commission.
Issued: March 17, 2008.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E8-5762 Filed 3-20-08; 8:45 am]
BILLING CODE 7020-02-P